Regeneron has released research on the company’s coronavirus antibody cocktail that found the cocktail retains its potency against the U.K. and South African variants of the virus. The study was done in conjunction with Columbia University researcher Dr. David Ho and has not yet been peer-reviewed. CNBC’s Meg Tirrell reports.
這就是下麵帖子所說的“再生元”。
